CureVac is a global biopharmaceutical company in the field of messenger RNA (mRNA) technology, with more than 20 years of expertise in developing and optimizing the versatile biological molecule for medical purposes. The principle of CureVac’s proprietary technology is the use of non-chemically modified mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a broad range of diseases.

Biotechnology

CureVac

CureVac's headquarters in Tübingen, Germany

The Wiesbaden office focuses on regulatory compliance, clinical development, and scientific research in the pharmaceutical sector.

Wiesbaden

The Amsterdam office focuses on strategic product development and manufacturing leadership in biopharmaceuticals.

Amsterdam

Andreas Bieber

Myriam Mendila

Ulrike Gnad-Vogt

Christian Ellinger

Dr. Philipp Bastian

Giulia di Domenico

Francois Kerendi

Julia Kurz

Allan Masterson. CPCC ACC

Axel Sven Malkomes

Malte Greune

Dr. Marco Rau

Dr. Yvonne Gebhardt

Arlène Derbaix

Dr. Dominik Esslinger

Michele Kindlein

Lisa Müller

Stefan Schaefer

Elisabeth Marshall

Emily Tuttle

Patrick Baumhof

Sandra Carbone

Pavel Tyan

Stefan O. Mueller

Frédéric F. Lehmann

Lisa-Marie Hack

Frederic Chevessier

Matias Julian Stagno

Alain Brecx

Fabio Montrasio

Markus Zettl

Nicolas van Boven

Ulrike Jaegle

Gianluca Quintini

Anna Mathes

Sandra Zellner

Thorsten Mutzke

Marshall Byrd

Anita Buck

Marcus Dalton

Magdalena Thole

Rüdiger Wolff

Stephan Voehringer

Dr. Sarah Fakih

Philip Stroisch

Lea Rudolph

Oliver Grupp

Marcus Cano

Nicoline Janssen

Carolin Eschenbach

Kerstin Seiffert

Stephanie Hauser

Craig A. Tooman

Baron Jean Stéphenne

Birgit Hofmann

Mehdi Shahidi

This department focuses on advancing scientific knowledge and developing innovative solutions through research.

Research and Development

The Quality Management Team at CureVac plays a critical role in ensuring that all processes and products meet stringent regulatory standards and industry best practices. This team oversees quality assurance, documentation, training, and compliance, facilitating seamless operations across the organization while ensuring the integrity and safety of CureVac's innovative mRNA therapies. Through effective management of quality agreements and material qualification, the team supports the overarching goal of delivering high-quality biopharmaceuticals to address various medical needs.

Quality Management Team

This department oversees the management and coordination of Chemistry, Manufacturing, and Controls processes to ensure compliance and efficiency in product development.

CMC Management

This department conducts scientific investigations and experiments to support product development and innovation.

Research Department

This department manages and oversees the planning and execution of clinical trials, ensuring compliance with regulatory standards and efficient supply chain logistics.

Clinical Operations

This department oversees the quality assurance processes for biological and microbiological products.

Quality Control

CureVac

Org chart

Board & advisors

Teams

Research and Development

Quality Management Team

CMC Management

Research Department

Clinical Operations

Quality Control

Offices

CureVac

Org chart

Board & advisors

Teams

Research and Development

Quality Management Team

CMC Management

Research Department

Clinical Operations

Quality Control

Offices

Related companies